ETF Managers Group, LLC Evaxion Biotech A/S Transaction History

ETF Managers Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.07 $11,232 - $21,551	-7,020 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.66 - $4.65 $53 - $93	20 Added 0.29%	7,020 $22,000
Q4 2021 Feb 14, 2022	BUY	$4.0 - $12.68 $564 - $1,787	141 Added 2.06%	7,000 $31,000
Q3 2021 Nov 15, 2021	BUY	$5.32 - $9.65 $6,368 - $11,551	1,197 Added 21.14%	6,859 $64,000
Q2 2021 Aug 16, 2021	SELL	$5.2 - $7.94 $1,331 - $2,032	-256 Reduced 4.33%	5,662 $43,000
Q1 2021 May 17, 2021	BUY	$5.3 - $9.95 $31,365 - $58,884	5,918 New	5,918 $31,000

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $33.8M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.